Alex Dorsch – CEO & Managing Director – Chalice Mining (ASX:CHN) is advancing the Gonneville Project—a major 2020 discovery in Western Australia with critical metals like platinum, nickel, and copper—towards development. The project boasts a tier-1 Mineral Resource Estimate, significant land in the new West Yilgarn Ni-Cu-PGE Province, and has earned multiple awards, including the 2023 Thayer Lindsley Award.
Copyright 2024 – Finance News Network
08 Aug 2023 - WT Financial Group Limited (ASX:WTL) Managing Director Keith Cullen discusses drivers of profitability, the effect of lower adviser numbers in the industry and opportunities moving forward.
09 Mar 2023 - Sequoia Financial Group Limited (ASX:SEQ) CEO and Managing Director Garry Crole discusses the 80 per cent sale of Morrison Securities to New Quantum.
09 Mar 2020 - Lithium Power International Limited (ASX:LPI) Managing Director and CEO Cristobal Garcia-Huidobro and Executive Director and CFO Andrew Phillips discuss the Environmental Approval for the company's Maricunga lithium brine project in Northern Chile, what this means for the project, and what’s planned.
14 Aug 2019 - ALE Property Group Limited (ASX:LEP) Managing Director, Andrew Wilkinson discusses the company’s FY19 results, valuations and rent reviews
04 Nov 2019 - Altura Mining (ASX:AJM) Managing Director James Brown, talks about its rights issue to raise $21M, production at its Pilgangoora mine in the Pilbara and outlook for lithium demand.
27 Sep 2024 - Martin Crabb, Chief Investment Officer at Shaw and Partners, speaks on the mixed market outlook. He discusses growth, financial conditions, central bank policies and valuations. He advocates for a cautious approach focused on stock picking in the current climate, favouring small caps over large caps.
28 Aug 2019 - Noxopharm Limited (ASX:NOX) CEO Dr Greg van Wyk discusses the company's anti-prostate cancer drug Veyonda, its efficacy in prostate cancer treatment, the drug’s upside and the company’s strategy for growth.
30 Jul 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses Phase III design for a trial in non-small cell lung cancer, positive results in head and neck cancer, and clearance for a Phase I study in autoimmune diseases.
27 Nov 2023 - Enlitic CEO Michael Sistenich discusses the company's AI solutions for healthcare data management as the company gears up for its December IPO.
24 Nov 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director Dr Michael Baker discusses the company's technology to convert solid dose drugs into oral sprays and the outlook for the year ahead.
